Paper
31 January 2012 Transcutaneous monitoring of steroid-induced osteoporosis with Raman spectroscopy
Jason R. Maher, Jason Inzana, Masahiko Takahata, Hani A. Awad, Andrew J. Berger
Author Affiliations +
Abstract
Although glucocorticoids are among the most frequently prescribed anti-inflammatory agents used in the treatment of rheumatoid arthritis, extended exposure to this steroid hormone is the leading cause of iatrogenic osteoporosis. Recently, Raman spectroscopy has been utilized to exploit biochemical differences between osteoporotic and normal bones in order to predict fracture risk. In this presentation, we report the results of ongoing research in our laboratory towards the clinical translation of this technique. We will discuss strategies for the transcutaneous acquisition of spectra from the tibiae of mice that are of sufficient quality to generate accurate predictions of fracture risk.
© (2012) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Jason R. Maher, Jason Inzana, Masahiko Takahata, Hani A. Awad, and Andrew J. Berger "Transcutaneous monitoring of steroid-induced osteoporosis with Raman spectroscopy", Proc. SPIE 8219, Biomedical Vibrational Spectroscopy V: Advances in Research and Industry, 82190P (31 January 2012); https://doi.org/10.1117/12.908361
Lens.org Logo
CITATIONS
Cited by 2 scholarly publications.
Advertisement
Advertisement
RIGHTS & PERMISSIONS
Get copyright permission  Get copyright permission on Copyright Marketplace
KEYWORDS
Bone

Raman spectroscopy

Tissues

Collagen

Data acquisition

Charge-coupled devices

Computer simulations

Back to Top